116 related articles for article (PubMed ID: 36918304)
21. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
22. Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.
Erbe AK; Wang W; Carmichael L; Hoefges A; Grzywacz B; Reville PK; Ranheim EA; Hank JA; Kim K; Seo S; Mendonca EA; Song Y; Kenkre VP; Hong F; Gascoyne RD; Paietta E; Horning SJ; Miller JS; Kahl B; Sondel PM
J Immunother Cancer; 2019 Mar; 7(1):70. PubMed ID: 30871628
[TBL] [Abstract][Full Text] [Related]
23. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
[TBL] [Abstract][Full Text] [Related]
25. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
26. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
27. KIR/HLA ligands immunogenetics markers associated with outcome of hepatitis B virus infection in the Bulgarian population.
Varbanova V; Popov G; Grigorova V; Petrova D; Naumova E; Mihaylova A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Sep; 165(3):270-276. PubMed ID: 32975242
[TBL] [Abstract][Full Text] [Related]
28. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
[TBL] [Abstract][Full Text] [Related]
29. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
[TBL] [Abstract][Full Text] [Related]
30. Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.
Vidal-Castiñeira JR; López-Vázquez A; Díaz-Peña R; Alonso-Arias R; Martínez-Borra J; Pérez R; Fernández-Suárez J; Melón S; Prieto J; Rodrigo L; López-Larrea C
J Virol; 2010 Jan; 84(1):475-81. PubMed ID: 19846535
[TBL] [Abstract][Full Text] [Related]
31. ERAP/HLA-C and KIR Genetic Profile in Couples with Recurrent Implantation Failure.
Piekarska K; Radwan P; Tarnowska A; Radwan M; Wilczyński JR; Malinowski A; Nowak I
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293373
[TBL] [Abstract][Full Text] [Related]
32. Distribution of killer cell immunoglobulin-like receptor genes and combinations with HLA-C ligands in an isolated Han population in southwest China.
Shi L; Shi L; Tao Y; Lin K; Liu S; Yu L; Yang Z; Yi W; Huang X; Sun H; Chu J; Yao Y
Tissue Antigens; 2011 Jul; 78(1):60-4. PubMed ID: 21542807
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
34. Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.
Canossi A; Aureli A; Del Beato T; Rossi P; Franceschilli L; De Sanctis F; Sileri P; di Lorenzo N; Buonomo O; Lauro D; Venditti A; Sconocchia G
J Transl Med; 2016 Aug; 14(1):239. PubMed ID: 27519478
[TBL] [Abstract][Full Text] [Related]
35. Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure.
Gil Laborda R; de Frías ER; Subhi-Issa N; de Albornoz EC; Meliá E; Órdenes M; Verdú V; Vidal J; Suárez E; Santillán I; Ordóñez D; Pintado-Vera D; González Villafáñez V; Lorenzo Á; Fariñas M; Rodríguez-Paíno M; Núñez Beltrán M; García Segovia Á; Del Olmo A; Martín Cañadas F; Daurelio R; de la Fuente A; González Casbas JM; Cabezuelo V; Ros Berruezo F; Moreno Hidalgo MÁ; Iniesta S; Bueno B; Martínez Acera Á; Izquierdo A; Vicario JL; Fernández-Arquero M; Sánchez-Ramón S
Sci Rep; 2024 Feb; 14(1):3354. PubMed ID: 38336826
[TBL] [Abstract][Full Text] [Related]
36. KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.
Campillo JA; Legaz I; López-Álvarez MR; Bolarín JM; Las Heras B; Muro M; Minguela A; Moya-Quiles MR; Blanco-García R; Martínez-Banaclocha H; García-Alonso AM; Alvarez-López MR; Martínez-Escribano JA
Immunogenetics; 2013 May; 65(5):333-43. PubMed ID: 23370861
[TBL] [Abstract][Full Text] [Related]
37. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
38. Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leucocyte Antigen C (HLA-C) Increase the Risk of Long-Term Chronic Liver Graft Rejection.
Legaz I; Bolarín JM; Campillo JA; Moya-Quiles MR; Miras M; Muro M; Minguela A; Álvarez-López MR
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293011
[TBL] [Abstract][Full Text] [Related]
39. Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus.
Hou Y; Zhang C; Xu D; Sun H
Clin Exp Immunol; 2015 May; 180(2):250-4. PubMed ID: 25581336
[TBL] [Abstract][Full Text] [Related]
40. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
